Publication | Open Access

Human target validation of phosphoinositide 3‐kinase (PI3K)β: effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor

Molecular PharmacologySignal TransductionBlood PlateletNovel Pi3kβ InhibitorMedicinePhysiologyDiabetesPlatelet AntagonistHuman Target ValidationPhosphoinositide 3‐KinasePharmacologyCell BiologyCell SignalingInsulin Signaling